Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Premier Biomedical, Inc. (BIEI) Featured In Wall Street Transcript Interview, Provides Insight To Revolutionary Medical Treatment R&D 0 comments
    May 1, 2013 11:04 AM | about stocks: BIEI

    Premier Biomedical president and CEO William Hartman was recently interviewed by The Wall Street Transcript (TWST), an independent investment publication, to discuss Premier's medical treatment research and development.

    In the interview, Hartman details the company's technology and unique approach to battle cancer. Utilizing the Felder Doctrine™ developed by company co-founder Dr. Mitchell Felder, Premier physically removes the pathophysiologic basis of a disease by processing the body fluids, such as blood for blood-borne diseases and cerebral spinal fluid for neurologic-based diseases.

    With this method, Premier has successfully eradicated a cancer tumor in a test tube by eliminating the molecular compounds integral to the growth factor of cancer. The company's procedure takes about 10 minutes, killing the cancer tumor within 24. The process is currently being tested in mice.

    Hartman also explained Premier's collaborative agreements with the University of Texas at El Paso (UTEP) and the William Beaumont Army Medical Center (WBAMC), through which Premier is collaborating with UTEP and WBAMC to complete research and development necessary to bring to market potential medications/procedures for its targeted diseases.

    "Exciting new technology developments are happening at Premier Biomedical and we are pleased to share our story with the prestigious readers of The Wall Street Transcript," Hartman stated in the press release. "As a public company, we are becoming more active in our direct communications with the investment community through our own announcements and through important venues like TWST."

    The interview appears in the publication's Biotechnology and Pharmaceuticals Report available by calling (212) 952-7433 or via The Wall Street Transcript Online (www.twst.com/report/1975).

    For more information, visit permierbiomedicalinc.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: BIEI
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.